Medidata Solutions, Inc. (MDSO): Vries Glen Michael De , President of Medidata Solutions, Inc. sold 32,500 shares on Jul 12, 2016. The Insider selling transaction was reported by the company on Jul 13, 2016 to the Securities and Exchange Commission. The shares were sold at $49.29 per share for a total value of $1,600,700.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jul 13, 2016, Tarek Sherif (Chairman & CEO) sold 22,036 shares at $49.24 per share price.On Jul 13, 2016, Steven Isaac Hirschfeld (Vice Chairman) sold 10,000 shares at $49.85 per share price.Also, On Jun 13, 2016, Vries Glen Michael De (President) sold 7,500 shares at $47.66 per share price.On Jun 2, 2016, Robert Taylor (director) sold 3,752 shares at $45.03 per share price.
Medidata Solutions Inc: On Monday, Jul 11, 2016 heightened volatility was witnessed in Medidata Solutions Inc which led to swings in the share price. The shares opened for trading at $48.61 and hit $50 on the upside , eventually ending the session at $49.33, with a gain of 2.41% or 1.16 points. The heightened volatility saw the trading volume jump to 5,12,235 shares. The 52-week high of the share price is $61.308 and the company has a market cap of $2,826 M . The 52-week low of the share price is at $30.22.
Company has been under the radar of several Street Analysts.Medidata Solutions Inc is Resumed by Needham to Buy and the brokerage firm has set the Price Target at $55. The Rating was issued on Jul 11, 2016.Medidata Solutions Inc is Downgraded by Jefferies to Underperform. Earlier the firm had a rating of Hold on the company shares. The Rating was issued on Apr 26, 2016.Medidata Solutions Inc is Initiated by Leerink Partners to Mkt Perform. The Rating was issued on Apr 26, 2016.Medidata Solutions Inc is Reiterated by Topeka Capital Markets to Buy and the brokerage firm has raised the Price Target to $ 51 from a previous price target of $44 .The Rating was issued on Apr 22, 2016.Medidata Solutions Inc is Reiterated by Needham to Buy and the brokerage firm has raised the Price Target to $ 57 from a previous price target of $45 .The Rating was issued on Apr 22, 2016.
Medidata Solutions Inc. (Medidata) provides cloud-based solutions for life sciences. The Company’s solutions are Medidata Rave an electronic data capture (EDC) and clinical data management system (CDMS) solution; Medidata CTMS a clinical trial management solution; Medidata Designer a protocol design tool; Medidata Insights which offer clinical business analytics and metrics; Medidata Balance a randomization and trial supply management solution; Medidata Patient Cloud an electronic patient-reported outcome (ePRO) application; Medidata Grants Manager which develops and manages trial budgets; Medidata contract research organizations (CRO) Contractor an analytics tool; Medidata SQM a set of cloud-based site quality management dashboards; Medidata Coder a medical coding and synonym management solution; Medidata Safety Gateway which collects and transmits events and related data from the EDC system and Medidata Targeted SDV which implements risk-based monitoring strategies.